Venus Concept to Release Second Quarter of Fiscal Year 2021 Financial Results on August 13, 2021
Venus Concept (NASDAQ: VERO) will announce its second quarter financial results for fiscal year 2021 on August 13, 2021, before market open. A conference call to discuss these results will occur at 8:00 a.m. ET the same day, with a Q&A session to follow. Interested parties may join by dialing 877-407-2991, or view the live webcast on the company's investor relations site. Venus Concept is recognized for its wide range of minimally invasive and non-invasive aesthetic technologies across over 60 countries, supporting a subscription-based sales model in North America.
- Innovative product portfolio including aesthetic device platforms and hair restoration systems.
- Presence in over 60 countries, enhancing market reach and brand recognition.
- Subscription-based business model in North America supports recurring revenue.
- None.
TORONTO, July 08, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that second quarter of fiscal year 2021 financial results will be released before the market opens on Friday, August 13, 2021.
Management will host a conference call at 8:00 a.m. Eastern Time on August 13, 2021 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13721406. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.
For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13721406. The webcast will be archived at ir.venusconcept.com.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 20 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, Venus Glow, Venus Bliss, Venus Epileve and Venus Viva MD. Venus Concept’s hair restoration systems include NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.
FAQ
When will Venus Concept release its Q2 2021 financial results?
What time is the conference call to discuss Venus Concept's Q2 2021 results?
How can I access the webcast of Venus Concept's Q2 2021 financial results?
What technologies does Venus Concept offer?
